CollPlant Names CFO Eran Rotem CEO, Replacing Yehiel Tal

• CollPlant Biotechnologies appointed Deputy CEO and Chief Financial Officer Eran Rotem as CEO, replacing Yehiel Tal, effective November 2, 2026.
• Tal also resigned as interim board chairman, effective the same date.
• The leadership change is part of a broader cost-reduction plan that includes discontinuing regenerative medicine research and development.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Collplant Biotechnologies Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-114972), on November 02, 2026, and is solely responsible for the information contained therein.